Drug usage and costs of children inpatients with bronchopneumonia in Karamay Central Hospital in 2014_Chinese Journal of Evidence-Based Medicine

Authors：

LIU Jianhong ¹ , YU Jiajie ² ,  ZHANG Weidong ¹ ,  LI Youping ² , WU Min ¹ , XU Ting ³ , XIE Yong ⁴ , LU Jing ³ , ZHANG Shengzhao ¹ , SUN Xin ² , SU Guanyue ²

1. Department of Pharmacy, Karamay Central Hospital, Karamay, 834000, P.R.China;
2. Chinese Evidence-Based Medicine Center, West China Hospital, Sichuan University, Chengdu, 610041, P.R.China;
3. Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, 610041, P.R.China;
4. Department of Pediatrics, Karamay Central Hospital, Karamay, 834000, P.R.China;

Corresponding?author：

ZHANG Weidong, Email: 0990end@sohu.com.cn; LI Youping, Email: yzmylab@hotmail.com

Keywords：

Children; Inpatients; Single disease; Bronchopneumonia; Evidence-based pharmacy; Rational drug use

DOI：

10.7507/1672-2531.201608044

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To investigate drug usage and costs of children inpatients with bronchopneumonia in Karamay Central Hospital in 2014 and to provide baseline for evidence-based pharmacy study of single disease in respiratory system. Methods The information of drug use and expenditure of children inpatients with bronchopneumonia were collected from the hospital information system (HIS). We analyzed the data including frequency, proportion and cumulative proportion by Excel 2007 software. Results A total of 890 children inpatients were included, the average age was 1.00±2.17 years old. Among the antibiotics of single therapy, the frequency of amoxicillin and clavulanate potassium for injection was highest. Among the antibiotics of combination therapy, the frequency of macrolides was highest. Conclusion The mainly drugs for treatment of children inpatients with bronchopneumonia in Karamay Central Hospital in 2014 is amoxicillin and clavulanate potassium for injection.

Citation： LIU Jianhong, YU Jiajie, ZHANG Weidong, LI Youping, WU Min, XU Ting, XIE Yong, LU Jing, ZHANG Shengzhao, SUN Xin, SU Guanyue. Drug usage and costs of children inpatients with bronchopneumonia in Karamay Central Hospital in 2014. Chinese Journal of Evidence-Based Medicine, 2017, 17(8): 876-879. doi: 10.7507/1672-2531.201608044 Copy

1.	國家衛生和計劃生育委員會. 中國衛生和計劃生育統計年鑒. 北京: 中國協和醫科大學出版社, 2014: 113-114.
2.	張衛東, 喻佳潔, 劉建紅, 等. 克拉瑪依市中心醫院 2014 年住院患者呼吸系統疾病構成和費用分析. 中國循證醫學雜志, 2017, 17(5): 507-510.
3.	馮江, 劉鳳玲, 衡萍, 等. 衡陽市某院 2013 年兒童疾病構成分析. 中國病案, 2015, 16(4): 53-55.
4.	中華醫學會兒科學分會呼吸學組, 《中華兒科雜志》編輯委員會. 兒童社區獲得性肺炎管理指南(2013 修訂) (上). 中華兒科雜志, 2013, 51(10): 745-752.
5.	中華醫學會兒科學分會呼吸學組, 《中華兒科雜志》編輯委員會. 兒童社區獲得性肺炎管理指南(2013 修訂) (下). 中華兒科雜志, 2013, 51(11): 856-862.
6.	Tapiainen T, Aittoniemi J, Immonen J, et al. Finnish guidelines for the treatment of community-acquired pneumonia and pertussis in children. Acta Pediatrica, 2016, 105(1): 39-43.
7.	Bradley JS, Byington CL, Shah SS, et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the pediatric infectious diseases society and the infectious diseases society of America. Clin Infect Dis, 2011, 53(7): 25-76.
8.	Harris M, Clark J, Coote N, et al. British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011. Thorax, 2011, 66(Suppl 2): 1-23.
9.	Zar HJ, Jeena P, Argent A, et al. Diagnosis and management of community-acquired pneumonia in childhood-South African Thoracic Society Guidelines. S Afr Med J, 2005, 95(12 Pt 2): 977-981, 984-990.
10.	孫博文, 董碧蓉. 糖皮質激素臨床濫用現狀及合理應用原則. 現代臨床醫學, 2014, 40(2): 154-156.

1. 國家衛生和計劃生育委員會. 中國衛生和計劃生育統計年鑒. 北京: 中國協和醫科大學出版社, 2014: 113-114.
2. 張衛東, 喻佳潔, 劉建紅, 等. 克拉瑪依市中心醫院 2014 年住院患者呼吸系統疾病構成和費用分析. 中國循證醫學雜志, 2017, 17(5): 507-510.
3. 馮江, 劉鳳玲, 衡萍, 等. 衡陽市某院 2013 年兒童疾病構成分析. 中國病案, 2015, 16(4): 53-55.
4. 中華醫學會兒科學分會呼吸學組, 《中華兒科雜志》編輯委員會. 兒童社區獲得性肺炎管理指南(2013 修訂) (上). 中華兒科雜志, 2013, 51(10): 745-752.
5. 中華醫學會兒科學分會呼吸學組, 《中華兒科雜志》編輯委員會. 兒童社區獲得性肺炎管理指南(2013 修訂) (下). 中華兒科雜志, 2013, 51(11): 856-862.
6. Tapiainen T, Aittoniemi J, Immonen J, et al. Finnish guidelines for the treatment of community-acquired pneumonia and pertussis in children. Acta Pediatrica, 2016, 105(1): 39-43.
7. Bradley JS, Byington CL, Shah SS, et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the pediatric infectious diseases society and the infectious diseases society of America. Clin Infect Dis, 2011, 53(7): 25-76.
8. Harris M, Clark J, Coote N, et al. British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011. Thorax, 2011, 66(Suppl 2): 1-23.
9. Zar HJ, Jeena P, Argent A, et al. Diagnosis and management of community-acquired pneumonia in childhood-South African Thoracic Society Guidelines. S Afr Med J, 2005, 95(12 Pt 2): 977-981, 984-990.
10. 孫博文, 董碧蓉. 糖皮質激素臨床濫用現狀及合理應用原則. 現代臨床醫學, 2014, 40(2): 154-156.

Chinese Journal of Evidence-Based Medicine

Drug usage and costs of children inpatients with bronchopneumonia in Karamay Central Hospital in 2014

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content